一名51岁的妇女患有渐进性呼吸不全和扩散双侧肺结节
Thitaya Boonsong1, Narongwit Nakwan1, Cheep Chareonlap2
1Division of Pulmonology, Department of Internal Medicine, Songkhla, Thailand.
Chest
|November 9, 2023
概括
一名妇女在接种COVID-19疫苗后出现呼吸短促. 肺部成像显示了分散的地面玻璃不透明度和结节,暗示了潜在的疫苗相关的肺部并发症.
科学领域:
- 肺部病理学 肺部病理学
- 疫苗学 疫苗学 疫苗学
- 放射学 放射学是一门学科.
背景情况:
- 由于COVID-19大流行,需要快速开发疫苗,包括ChAdOx1-S (重组) 疫苗.
- 疫苗接种后的不良事件在公共卫生和患者安全方面受到密切监测.
- 接种疫苗后的肺部并发症需要彻底调查.
研究的目的:
- 在COVID-19疫苗接种后,在运动时呈现渐进性呼吸障碍病例.
- 调查ChAdOx1-S疫苗与新出现的呼吸道症状之间的潜在联系.
- 在怀疑疫苗相关肺部疾病的患者中记录放射性发现.
主要方法:
- 一个51岁的女性患者的病例报告.
- 临床病史,包括疫苗接种情况和症状发作.
- 对胸部X射线扫描结果的审查.
主要成果:
- 患者在ChAdOx1-S疫苗接种后两个月出现了运动性呼吸障碍.
- 胸部X射线扫描显示了分散的地面玻璃不透明度和双边肺结节.
- 没有典型的传染性或自身免疫性疾病症状.
结论:
- 这一案例突出了COVID-19疫苗接种后潜在的,尽管很少见的肺部表现.
- 需要进一步的研究来了解这种疫苗接种后肺部事件的机制和发生率.
- 疫苗接种后对非典型呼吸道症状的警对于早期诊断和管理至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Pathogenesis and Clinical Features
302
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
302
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Other Pulmonary Disorders
853
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
853


